Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children.
暂无分享,去创建一个
D. Rabier | J. Saudubray | P. Jouvet | D. Bonnet | P. Lonlay | E. Villain | M. Brivet | D. Martin | Pascale De Lonlay
[1] D. Bonnet,et al. Fatty acid β-oxidation deficiency masquerading as fulminant myocarditis , 1998 .
[2] T. Cowan,et al. Retrospective biochemical screening of fatty acid oxidation disorders in postmortem livers of 418 cases of sudden death in the first year of life. , 1998, The Journal of pediatrics.
[3] D. Bonnet,et al. Tachycardies ventriculaires néonatales. , 1998 .
[4] P. Rustin,et al. Efficiency of metabolic screening in childhood cardiomyopathies. , 1998, European heart journal.
[5] N. Gregersen,et al. Fatty acid oxidation disorders as primary cause of sudden and unexpected death in infants and young children: an investigation performed on cultured fibroblasts from 79 children who died aged between 0-4 years. , 1997, Molecular pathology : MP.
[6] R. Weingart,et al. Modulation of cardiac gap junctions: the mode of action of arachidonic acid. , 1997, Journal of Molecular and Cellular Cardiology.
[7] J. Horowitz,et al. Inhibition of carnitine palmitoyltransferase-1 in rat heart and liver by perhexiline and amiodarone. , 1996, Biochemical pharmacology.
[8] A. Leaf,et al. Protective effects of free polyunsaturated fatty acids on arrhythmias induced by lysophosphatidylcholine or palmitoylcarnitine in neonatal rat cardiac myocytes. , 1996, European journal of pharmacology.
[9] M. Bennett,et al. Inborn errors of metabolism diagnosed in sudden death cases by acylcarnitine analysis of postmortem bile. , 1995, Clinical chemistry.
[10] C. Malloy,et al. Direct Evidence That Perhexiline Modifies Myocardial Substrate Utilization from Fatty Acids to Lactate , 1995, Journal of cardiovascular pharmacology.
[11] A. Legrand,et al. Rapid Diagnosis of Long Chain and Medium Chain Fatty Acid Oxidation Disorders Using Lymphocytes , 1995, Annals of clinical biochemistry.
[12] J. Saudubray,et al. Inborn Metabolic Diseases: Diagnosis and Treatment , 1995 .
[13] M. Arita,et al. [Cellular electrophysiological basis of proarrhythmic and antiarrhythmic effects of ischemia-related lipid metabolites]. , 1993, Rinsho byori. The Japanese journal of clinical pathology.
[14] S. Pande,et al. Carnitine-acylcarnitine translocase deficiency with severe hypoglycemia and auriculo ventricular block. Translocase assay in permeabilized fibroblasts. , 1993, The Journal of clinical investigation.
[15] M. Bacaner,et al. Long-chain fatty acids activate calcium channels in ventricular myocytes. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[16] D. Valle,et al. Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake , 1991, Annals of neurology.
[17] R. Gilbert,et al. Inherited metabolic diseases in the sudden infant death syndrome. , 1991, Archives of disease in childhood.
[18] S. Pogwizd,et al. Amphipathic lipid metabolites and their relation to arrhythmogenesis in the ischemic heart. , 1991, Journal of molecular and cellular cardiology.
[19] P. Rizzon,et al. High doses of L-carnitine in acute myocardial infarction: metabolic and antiarrhythmic effects. , 1989, European heart journal.
[20] P. Corr,et al. Prophylaxis of early ventricular fibrillation by inhibition of acylcarnitine accumulation. , 1989, The Journal of clinical investigation.
[21] K. Gibson,et al. Oxidation of Fatty Acids in Cultured Fibroblasts: a Model System for the Detection and Study of Defects in Oxidation , 1982, Pediatric Research.
[22] I. Karl,et al. Lipid transport in the human newborn. Palmitate and glycerol turnover and the contribution of glycerol to neonatal hepatic glucose output. , 1982, The Journal of clinical investigation.
[23] M. Katcher,et al. Systemic carnitine deficiency presenting as familial endocardial fibroelastosis: a treatable cardiomyopathy. , 1981, The New England journal of medicine.
[24] S. Ruddy,et al. Congenital Heart Block in Newborns of Mothers with Connective Tissue Disease , 1977, Circulation.
[25] P. Ott. Ventricular arrhythmias , 2000, Current treatment options in cardiovascular medicine.
[26] R. Campbell,et al. Paediatric cardiac arrhythmias , 1996 .